Ondansetron for hallucinosis in advanced Parkinson's disease

Joseph Zoldan, Gali Friedberg, Hadassah Goldberg-Stern, Eldad Melamed

Research output: Contribution to journalLetterpeer-review

88 Scopus citations
Original languageEnglish
Pages (from-to)562-563
Number of pages2
JournalThe Lancet
Volume341
Issue number8844
DOIs
StatePublished - 27 Feb 1993
Externally publishedYes

Bibliographical note

Funding Information:
In investigation of possible serconversions, it is easy to overlook sources of passive antibody transfer, as shown in a report of cytomegalovirus immunoglobulin that also contained antibody to HCV.6 Unpooled blood components and lower purity clotting factor concentrates within 6-8 months should also be considered before necessarily attributing detectable antibody to previous or recent infection. Passively induced anti-HAV could not account for the reported European clusters of HAV infection because essentially all cases were clinically ill and icteric, and were seropositive for anti-HAV-IgM. We are reassured about the safety of solvent/ detergent-processed clotting factor concentrates, with respect to HAV, that are available in the USA. Supported by contracts no NOI-HB-4-7003 and 9-7074 of the National Heart, Lung, and Blood Institute, USA.

Funding

In investigation of possible serconversions, it is easy to overlook sources of passive antibody transfer, as shown in a report of cytomegalovirus immunoglobulin that also contained antibody to HCV.6 Unpooled blood components and lower purity clotting factor concentrates within 6-8 months should also be considered before necessarily attributing detectable antibody to previous or recent infection. Passively induced anti-HAV could not account for the reported European clusters of HAV infection because essentially all cases were clinically ill and icteric, and were seropositive for anti-HAV-IgM. We are reassured about the safety of solvent/ detergent-processed clotting factor concentrates, with respect to HAV, that are available in the USA. Supported by contracts no NOI-HB-4-7003 and 9-7074 of the National Heart, Lung, and Blood Institute, USA.

FundersFunder number
National Heart, Lung, and Blood Institute

    Cite this